Earnings ·
Thermo Fisher reports Q3 revenue of $12.14B and adjusted EPS of $6.68
TMOThermo Fisher Scientific Inc.
Thermo Fisher Scientific reported third-quarter 2026 financial results with revenue growing 9% to $12.14 billion, driven by a 6% increase in organic sales. GAAP diluted earnings per share rose 9% to $4.64, while adjusted EPS increased 15% to $6.68. The company also completed the previously announced divestiture of its microbiology business during the quarter and highlighted new product launches including the Orbitrap Isora mass spectrometer and FDA-cleared EliA CTD 13 Screen. Thermo Fisher Scientific Inc. is a global leader in serving science, providing analytical instruments, lab equipment, reagents, software, and services to life sciences research, healthcare, and industrial sectors.